Prevalence of M4 macrophages within human coronary atherosclerotic plaques is associated with features of plaque instability

International Journal of Cardiology

Volumn 186, Issue , 2015, Pages 219-225

  Erbel, Christian ^a,b   Wolf, Antonia ^a   Lasitschka, Felix ^a   Linden, Fabian ^a   Domschke, Gabriele ^a   Akhavanpoor, Mohammadreza ^a   Doesch, Andreas O ^a,b   Katus, Hugo A ^a,b   Gleissner, Christian A ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

Atherosclerosis; Coronary artery disease; Macrophage; Unstable plaque

Indexed keywords

CALGRANULIN A; CD68 ANTIGEN; EOSIN; HEMATOXYLIN; MATRILYSIN; BIOLOGICAL MARKER; THROMBOCYTE FACTOR 4;

ADULT; ADVENTITIA; AGE; ARTERY MEDIA; ARTICLE; CARDIOVASCULAR RISK; CD68+ MACROPHAGE; CELLULAR DISTRIBUTION; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; INTIMA; ISCHEMIC CARDIOMYOPATHY; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MMP7+ S100A8+ CD68+ M4 MACROPHAGE; MOUSE; MULTIVARIATE ANALYSIS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; STAINING; STARY CLASSIFICATION; ATHEROSCLEROTIC PLAQUE; CORONARY BLOOD VESSEL; DISEASE COURSE; FEMALE; FOLLOW UP; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; BIOMARKERS; CORONARY ARTERY DISEASE; CORONARY VESSELS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; PLATELET FACTOR 4; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84928921003     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.03.151     Document Type: Article

References (29)

1. V.L. Roger, A.S. Go, D.M. Lloyd-Jones, R.J. Adams, J.D. Berry, and T.M. Brown Heart disease and stroke statistics - 2011 update: a report from the American Heart Association Circulation 123 2011 e18 e209
2. E. Galkina, and K. Ley Immune and inflammatory mechanisms of atherosclerosis (∗) Annu. Rev. Immunol. 27 2009 165 197
3. I.M. Wolfs, M.M. Donners, and M.P. de Winther Differentiation factors and cytokines in the atherosclerotic plaque micro-environment as a trigger for macrophage polarisation Thromb. Haemost. 106 2011 763 771
4. G. Chinetti-Gbaguidi, S. Colin, and B. Staels Macrophage subsets in atherosclerosis Nat. Rev. Cardiol. 12 2015 10 17
5. F.O. Martinez, S. Gordon, M. Locati, and A. Mantovani Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression J. Immunol. 177 2006 7303 7311
6. C.A. Gleissner Platelet-derived chemokines in atherogenesis: what's new? Curr. Vasc. Pharmacol. 10 2012 563 569
7. C.A. Gleissner, P. von Hundelshausen, and K. Ley Platelet chemokines in vascular disease Arterioscler. Thromb. Vasc. Biol 28 2008 1920 1927
8. B.S. Sachais, T. Turrentine, J.M. Dawicki McKenna, A.H. Rux, D. Rader, and M.A. Kowalska Elimination of platelet factor 4 (PF4) from platelets reduces atherosclerosis in C57Bl/6 and apoE-/- mice Thromb. Haemost. 98 2007 1108 1113
9. C.A. Gleissner, and K. Ley CXCL4 in atherosclerosis: possible roles in monocyte arrest and macrophage foam cell formation Thromb. Haemost. 98 2007 917 918
10. B. Scheuerer, M. Ernst, I. Durrbaum-Landmann, J. Fleischer, E. Grage-Griebenow, and E. Brandt The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages Blood 95 2000 1158 1166
11. C.A. Gleissner, I. Shaked, K.M. Little, and K. Ley CXC chemokine ligand 4 induces a unique transcriptome in monocyte-derived macrophages J. Immunol. 184 2010 4810 4818
12. C.A. Gleissner, I. Shaked, C. Erbel, D. Bockler, H.A. Katus, and K. Ley CXCL4 downregulates the atheroprotective hemoglobin receptor CD163 in human macrophages Circ. Res. 106 2010 203 211
13. C.A. Gleissner Macrophage phenotype modulation by CXCL4 in atherosclerosis Front. Physiol. 3 2012 1
14. C. Erbel, M. Tyka, C.M. Helmes, M. Akhavanpoor, G. Rupp, and G. Domschke CXCL4-induced plaque macrophages can be specifically identified by co-expression of MMP7+S100A8+ in vitro and in vivo Innate Immun. 21 2015 255 265
15. P.K. Whelton Epidemiology of hypertension Lancet 344 1994 101 106
16. S.M. Grundy, J.I. Cleeman, C.N. Merz, H.B. Brewer Jr., L.T. Clark, and D.B. Hunninghake Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines Circulation 110 2004 227 239
17. H.C. Stary, A.B. Chandler, R.E. Dinsmore, V. Fuster, S. Glagov, and W. Insull Jr. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association Circulation 92 1995 1355 1374
18. Y. Huo, A. Schober, S.B. Forlow, D.F. Smith, M.C. Hyman, and S. Jung Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E Nat. Med. 9 2003 61 67
19. P. von Hundelshausen, R.R. Koenen, M. Sack, S.F. Mause, W. Adriaens, and A.E. Proudfoot Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium Blood 105 2005 924 930
20. R.R. Koenen, P. von Hundelshausen, I.V. Nesmelova, A. Zernecke, E.A. Liehn, and A. Sarabi Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice Nat. Med. 15 2009 97 103
21. M.A. Ingersoll, R. Spanbroek, C. Lottaz, E.L. Gautier, M. Frankenberger, and R. Hoffmann Comparison of gene expression profiles between human and mouse monocyte subsets Blood 115 2010 e10 e19
22. J. Seok, H.S. Warren, A.G. Cuenca, M.N. Mindrinos, H.V. Baker, and W. Xu Genomic responses in mouse models poorly mimic human inflammatory diseases Proc. Natl. Acad. Sci. 110 2013 3507 3512
23. S. Pitsilos, J. Hunt, E.R. Mohler, A.M. Prabhakar, M. Poncz, and J. Dawicki Platelet factor 4 localization in carotid atherosclerotic plaques: correlation with clinical parameters Thromb. Haemost. 90 2003 1112 1120
24. Z.S. Galis, and J.J. Khatri Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly Circ. Res. 90 2002 251 262
25. A.C. Newby Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture Physiol. Rev. 85 2005 1 31
26. S. Jormsjo, C. Whatling, D.H. Walter, A.M. Zeiher, A. Hamsten, and P. Eriksson Allele-specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patients Arterioscler. Thromb. Vasc. Biol. 21 2001 1834 1839
27. X.F. Hu, X.P. Jin, P.Y. Hu, M. Zhu, F. Wang, and X.F. Lin Association of a functional polymorphism in the MMP7 gene promoter with susceptibility to vulnerable carotid plaque in a Han Chinese population Clin. Chem. Lab. Med. 49 2011 1735 1741
28. H. Williams, J.L. Johnson, C.L. Jackson, S.J. White, and S.J. George MMP-7 mediates cleavage of N-cadherin and promotes smooth muscle cell apoptosis Cardiovasc. Res. 87 2010 137 146
29. H.C. Stary Natural history and histological classification of atherosclerotic lesions: an update Arterioscler. Thromb. Vasc. Biol. 20 2000 1177 1178